Spectrum Pharmaceuticals Inc (NASDAQ:SPPI)

6.22
Delayed Data
As of May 28
 -0.02 / -0.32%
Today’s Change
5.45
Today|||52-Week Range
9.27
-10.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$418.0M

Company Description

Spectrum Pharmaceuticals, Inc. engages in the development and manufacture of pharmaceutical products. The firm acquires, develops, and commercializes a pipeline of clinical and commercial products under the FUSILEV, FOLOTYN, ZEVALIN, MARQIBO, and BELEODAQ brands. It operates through the United States and International geographical segments. The company was founded in December 1987 and is headquartered in Henderson, NV.

Contact Information

Spectrum Pharmaceuticals, Inc.
11500 South Eastern Avenue
Henderson Nevada 89052
P:(702) 835-6300
Investor Relations:

Employees

Shareholders

Individual stakeholders5.64%
Other institutional48.71%
Mutual fund holders38.31%

Top Executives

Rajesh C. ShrotriyaChairman & Chief Executive Officer
Joseph G. TurgeonPresident & Chief Operating Officer
Kurt A. GustafsonCFO, Executive VP & Principal Accounting Officer
Lee F. AllenChief Medical Officer & Senior Vice President
Thomas J. RigaChief Commercial Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account